Loading quote...
Amylyx Pharmaceuticals, Inc. (AMLX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Global Select. The most recent ex-dividend date was March 28, 2018, with payment scheduled for April 2, 2018. market capitalization is approximately $1.24B.